Connect Biopharma Holdings (CNTB) Enterprise Value (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Enterprise Value of -$46.0 million for Q1 2026, down 3.81% sequentially from -$44.3 million in Q4 2025, and up 45.2% YoY from -$31.7 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Enterprise Value (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Enterprise Value for 7 years, with the latest figure at -$46.0 million in Q1 2026.
- Quarterly Enterprise Value rose 45.2% year-over-year to -$46.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$46.0 million (up 45.2% YoY) and the FY2025 annual result came in at -$44.3 million, up 52.69% from the prior year.
- Enterprise Value declined to -$46.0 million in Q1 2026 per CNTB's latest filing, from -$44.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$44.3 million in Q4 2025 and troughed at -$194.0 million in Q2 2022.
- A 5-year average of -$100.2 million and a median of -$93.7 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value increased 18.81% in 2024, then jumped 52.69% in 2025.
- Over 5 years, Enterprise Value stood at -$149.3 million in 2022, then climbed by 20.74% to -$118.3 million in 2023, then increased by 20.77% to -$93.7 million in 2024, then jumped by 52.69% to -$44.3 million in 2025, then decreased by 3.81% to -$46.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$46.0 million, -$44.3 million, and -$54.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Connect Biopharma Holdings | 144.32 Mn | 144.32 Mn | - | -31.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.52 Mn |
| Mar 31, 2026 | -46.03 Mn |
| Dec 31, 2025 | -44.35 Mn |
| Sep 30, 2025 | -54.78 Mn |
| Jun 30, 2025 | -71.77 Mn |
| Mar 31, 2025 | -84.01 Mn |
| Dec 31, 2024 | -93.73 Mn |
| Jun 30, 2024 | -110.20 Mn |
| Dec 31, 2023 | -118.30 Mn |
| Jun 30, 2023 | -135.73 Mn |
| Dec 31, 2022 | -149.25 Mn |
| Jun 30, 2022 | -194.02 Mn |
| Dec 31, 2021 | -266.97 Mn |
| Dec 31, 2020 | -154.39 Mn |